Prepare for the 2026 CMS Mandate with Glytec’s comprehensive guide. Learn More

Stop Preventable Harm

Manage Glycemic Risk Across Your Health System with GlytecOne

Glytec’s Intelligent Glycemic Management platform helps replace reactive insulin management with FDA-cleared insulin dosing guidance, systemwide visibility, and the clinical partnership to help strengthen your CMS glycemic eCQM readiness.

400+

hospital clients

100+

patents

16 years

of innovation

50B+

data points

FDA-cleared

Glucommander®

Introducing GlytecOne: For Every Hospital. For Every Patient.

The first unified glycemic management platform that integrates clinical decision support, workflow automation, performance analytics, and enterprise population health intelligence. GlytecOne connects every care team member and hospital leader with the data and tools to help deliver safer, more consistent glucose management across your entire health system.

Care Enablement

FDA-cleared insulin dosing guidance and standardized clinical workflows.

Decision Support

Current patient visibility and structured clinical review through Command Center.

Performance Insights

Enterprise analytics, benchmarking, and eCQM-aligned reporting through Command Center.

Population Health

Enterprise-wide glycemic intelligence for health system leaders and health plan partners.

Stop High-Risk Manual Protocols.
Start Delivering Safer Glycemic Care.

CLIENTS

The Intelligent Glycemic Management Platform

Are You CMS eCQM Ready?

CMS now requires hospitals to report severe hypoglycemia and severe hyperglycemia as hospital harm eCQMs. The 2026 measurement period is active. Is your organization prepared?

Measurement period began January 1, 2026

Days remaining in the 2026 measurement period.

Glytec’s Numbers Speak for Themselves

GlytecOne helps hospitals reduce glycemic variability, supports safer insulin management, and strengthens performance across clinical, operational, and financial measures.

Financial Outomes
  • 6-8x ROI
  • 62% Improvement over Competition
  • $10k+ Avg Cost Savings per Severe Hypo Event
Clinical Outcomes
  • 47% Nurse Time Savings
  • 30 min Per Shift Savings*
  • 90% Satisfaction
Patient Outcomes
  • 99.8% Reduction in Inpatient Hypoglycemia
  • 3.1% Reduction in A1C
  • 68% Reduction in 30-Day Readmissions**

*Up to 20 minutes    **Up to 68%

What Glytec Partners are Saying

Laurie Porcaro

Laurie Porcaro

Diabetes Clinical Manager

H. Coutenay Harrison Jr.

H. Coutenay Harrison Jr.

MD Endocrinology, Diabetes & Metab...

Sylvia Elledge

Sylvia Elledge

Process Improvement Specialist RN

Barbara McLean

Barbara McLean

MR, RN, CCNS-BC, NP-BC, CCRN, FC...

AFFILIATIONS & AWARDS

Book a Discussion

See how your manual glycemic workflows are creating avoidable risk.